Pharmapark is a privately-owned Russian biopharmaceutical company that is focused on development, manufacture and commercialization of biosimilar products. The company possesses the know-how and has a successful track record performing complete biotechnological drug development through commercial production. Pharmapark has successfully marketed 5 biosimilar products and has in-house pipeline of novel formulations and biosimilars focused on value-adding treatments.
View Top Employees from Pharmapark LlcWebsite | http://www.pharmapark.ru/en/ |
Revenue | $5 million |
Employees | 10 (1 on RocketReach) |
Address | 13 Oktyabrskaya St, Krasnogorsk, Moscow Oblast 143402, RU |
Phone | +7 495 644-00-59 |
Fax | +7 495 502-16-43 |
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Pharmapark Llc employee's phone or email?
The Pharmapark Llc annual revenue was $5 million in 2023.
Veiko Saluste is the CEO of Pharmapark Llc.
1 people are employed at Pharmapark Llc.
Pharmapark Llc is based in Krasnogorsk, Moscow Oblast.
The NAICS codes for Pharmapark Llc are [3254, 325, 32541, 32].
The SIC codes for Pharmapark Llc are [28, 283].